Suppr超能文献

脂质合成与加工蛋白ABHD5、PGRMC1和角鲨烯合酶可作为皮脂腺肿瘤新的免疫组化标志物,并能将皮脂腺癌与皮脂腺瘤以及具有透明细胞特征的基底细胞癌区分开来。

Lipid synthesis and processing proteins ABHD5, PGRMC1 and squalene synthase can serve as novel immunohistochemical markers for sebaceous neoplasms and differentiate sebaceous carcinoma from sebaceoma and basal cell carcinoma with clear cell features.

作者信息

Chen Wei-Shen, Chen Pei-Ling, Li Jianping, Lind Anne C, Lu Dongsi

机构信息

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.

出版信息

J Cutan Pathol. 2013 Jul;40(7):631-8. doi: 10.1111/cup.12147. Epub 2013 Apr 5.

Abstract

BACKGROUND

Sebaceous carcinoma represents a rare and potentially fatal adnexal malignancy. Poorly-differentiated sebaceous carcinoma consisting of infiltrative basaloid tumor cells with inapparent lipid vesicles can mimic basal cell carcinoma (BCC). Conversely, other epithelial tumors can exhibit clear cell histopathology and mimic sebaceous carcinoma. At the present time, immunohistochemical markers unique for sebaceous carcinoma are limited.

METHODS

We evaluated the expression of three lipid synthesis/processing protein markers alpha/beta hydrolase domain-containing protein 5 (ABHD5), progesterone receptor membrane component-1 (PGRMC1) and squalene synthase (SQS) in sebaceous carcinoma and investigated their utility in differentiating sebaceous tumors from BCC with clear cell features. Immunohistochemistry was performed on 23 sebaceous carcinomas, 14 sebaceomas and 14 BCCs with clear cell features.

RESULTS

In sebaceous carcinomas, ABHD5 showed dispersed, cytoplasmic punctate and/or vesicular staining (n = 19/23, 83%), while PGRMC1 and SQS each showed vesicular and membranous staining in tumor cells (n = 22/23, 96%). In all sebaceomas, these markers highlighted tightly clustered lipid vesicles in sebocytes. All BCCs with clear cell features were negative for these three markers.

CONCLUSION

ABHD5, PGRMC1 and SQS are novel markers for sebaceous carcinoma and can reliably distinguish sebaceous neoplasms from non-sebaceous tumors, specifically BCC with clear cell features.

摘要

背景

皮脂腺癌是一种罕见且可能致命的附属器恶性肿瘤。由浸润性基底样肿瘤细胞组成且脂滴不明显的低分化皮脂腺癌可酷似基底细胞癌(BCC)。相反,其他上皮性肿瘤可表现为透明细胞组织病理学特征并酷似皮脂腺癌。目前,皮脂腺癌特有的免疫组化标志物有限。

方法

我们评估了三种脂质合成/加工蛋白标志物,即含α/β水解酶结构域蛋白5(ABHD5)、孕激素受体膜成分-1(PGRMC1)和角鲨烯合酶(SQS)在皮脂腺癌中的表达,并研究了它们在鉴别皮脂腺肿瘤与具有透明细胞特征的BCC中的作用。对23例皮脂腺癌、14例皮脂腺瘤和14例具有透明细胞特征的BCC进行了免疫组化检测。

结果

在皮脂腺癌中,ABHD5呈散在、胞质点状和/或泡状染色(n = 19/23,83%),而PGRMC1和SQS在肿瘤细胞中均呈泡状和膜状染色(n = 22/23,96%)。在所有皮脂腺瘤中,这些标志物突出显示皮脂腺细胞中紧密聚集的脂滴。所有具有透明细胞特征的BCC对这三种标志物均为阴性。

结论

ABHD5、PGRMC1和SQS是皮脂腺癌的新型标志物,可可靠地将皮脂腺肿瘤与非皮脂腺肿瘤,特别是具有透明细胞特征的BCC区分开来。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验